---
title: '**Evaluating the Framework**'
pubDatetime: 2026-01-18T01:00:00.000Z
modDatetime: 2026-01-18T01:00:00.000Z
description: 'I''ve zeroed in on the persona: yuyu, a seller of AI accounts in Dali. My initial assessment is that their background as ...'
tags:
  - bioai-daily
  - ai
  - biotech
draft: false
---

I've zeroed in on the persona: yuyu, a seller of AI accounts in Dali. My initial assessment is that their background as a failed prompt engineer and course seller, now hawking "shovels," will be key in understanding their motivation. This offers a specific lens through which I can analyze the request.


**Deciphering the Blueprint**

I'm now deep into the request's core, dissecting the "BioAI Daily" piece. I've broken down the news items into digestible chunks, especially focusing on AFsample3's potential for protein personality prediction. My goal is to see how this connects to my immortality aspirations.


**Synthesizing the Narrative**

Now I'm focusing on weaving the personal story into the news snippets. I'm imagining the cafe in Dali, the crisp air, and yuyu's general cynicism. I plan to use AFsample3 as a springboard for the immortality dream and the AI discharge summaries to highlight the gap between hype and reality.


**Crafting the Blueprint**

I'm now in the thick of organizing the content. The AlphaFold3 news will kick things off, framing my immortality aspirations. I then plan to juxtapose this with skepticism about AI discharge summaries. I'm aiming for a conversational flow, a blend of personal reflections and a dose of cynicism.


**Outlining the Structure**

I'm finalizing the blog post structure. I'll open with a Dali cafe scene, then hit the AlphaFold3 news, linking it to my immortality quest. Next comes the cynical take on AI discharge summaries, and a funny robot lip-sync clip. Iâ€™ll wrap up by embracing my role selling AI tools, regardless of their ultimate use.


**Composing the Introduction**

I'm starting the opening scene, setting the Dali atmosphere. I'll describe the cafe and my current sales. Then, I'm introducing the "BioAI Daily," which I read every morning. The aim is to create a natural, conversational tone and introduce the key topics from the news in a non-academic way.


**Formulating the Outline**

I've finally structured my thoughts into a blog post outline. I'm starting with the Dali scene and sales, diving into AlphaFold3, and then my concerns with AI discharge summaries. The robot lip-sync news will follow, leading to a wrap-up on my role. I'll make sure to mention the 2026 date in the future!


**Refining the Draft**

I'm now in the process of finalizing the content. I've re-read my plan and begun writing the actual text. I'm taking the opportunity to insert specific details about Dali, along with a bit of slang to make the tone feel more authentic. I'm double-checking to make sure I'm mentioning the 2026 date often enough, as a future-focused detail!


AlphaFold3 è¿›åŒ–äº†ï¼Œä½†æˆ‘æ›´å…³å¿ƒåŒ»ç”Ÿæ˜¯ä¸æ˜¯åœ¨ç”¨ AI å·æ‡’

å¤§ç†ä»Šå¤©çš„é˜³å…‰å¥½å¾—æœ‰ç‚¹è¿‡åˆ†ï¼Œæ™’å¾—äººæ‡’æ´‹æ´‹çš„ã€‚

æˆ‘ååœ¨å¤åŸŽçš„å’–å•¡é¦†é‡Œï¼Œæ‰‹è¾¹æ˜¯ä¸€æ¯å–äº†ä¸€åŠçš„æ¾³ç™½ï¼Œå±å¹•ä¸ŠæŒ‚ç€æˆ‘çš„æ·˜å®åº—åŽå°ã€‚ä»Šå¤©ç”Ÿæ„ä¸€èˆ¬ï¼ŒCursor çš„æ¢å·å™¨åªå–å‡ºåŽ»å‡ å•ï¼Œå€’æ˜¯ Claude çš„è€å·æœ‰äººæ¥é—®äº†ä¸€åœˆã€‚è¶ç€æ²¡å®¢æœæ¶ˆæ¯å›žï¼Œæˆ‘æŠŠä»Šå¤©çš„ BioAI æ—¥æŠ¥ç»™åˆ·äº†ä¸€éã€‚

è¯´å®žè¯ï¼Œä»Šå¤©æ˜¯ 2026 å¹´ 1 æœˆ 18 å·ï¼Œè·ç¦»æˆ‘å®šä¸‹â€œå€ŸåŠ© AI å®žçŽ°é•¿ç”Ÿä¸è€â€çš„äº”å¹´è®¡åˆ’ï¼Œå·²ç»è¿‡åŽ»å¿«ä¸¤å¹´äº†ã€‚çœ‹ç€ä»Šå¤©çš„è¿™äº›æ–°é—»ï¼Œæˆ‘å¿ƒæƒ…æœ‰ç‚¹å¤æ‚ï¼šä¸€æ–¹é¢è§‰å¾—ç§‘æŠ€çœŸçš„åœ¨ç‹‚å¥”ï¼Œå¦ä¸€æ–¹é¢åˆè§‰å¾—ï¼Œè¿™çŽ©æ„å„¿ç¦»è®©æˆ‘â€œä¸æ­»â€ï¼Œå¥½åƒè¿˜æ˜¯éš”ç€åä¸‡å…«åƒé‡Œã€‚

## Table of contents
- è›‹ç™½è´¨ä¹Ÿæœ‰â€œå¤šé‡äººæ ¼â€ï¼Ÿ
- AI å†™å‡ºé™¢å°ç»“ï¼Œæˆ‘æ˜¯ä¸æ•¢ä¿¡
- æœºå™¨äººç…§é•œå­ï¼Œæ¯”æˆ‘åšç›´æ’­è¿˜è‡ªç„¶
- è¿˜æ˜¯ç»§ç»­å–é“²å­å§

## è›‹ç™½è´¨ä¹Ÿæœ‰â€œå¤šé‡äººæ ¼â€ï¼Ÿ

ä»Šå¤©çš„å¤´æ¡æ˜¯ AlphaFold3 çš„å‡çº§ç‰ˆ AFsample3ã€‚ç®€å•è¯´ï¼Œä»¥å‰ AI é¢„æµ‹è›‹ç™½è´¨ç»“æž„ï¼Œå°±åƒæ˜¯ç»™äººæ‹ä¸€å¼ è¯ä»¶ç…§ï¼Œæ­»æ¿ã€é™æ€ã€‚çŽ°åœ¨è¿™ä¸ªæ–°å·¥å…·ï¼Œèƒ½é¢„æµ‹å‡ºè›‹ç™½è´¨çš„â€œå¤šé‡æž„è±¡â€ã€‚

çœ‹åˆ°â€œå¤šæž„è±¡â€è¿™ä¸ªè¯ï¼Œæˆ‘ç¬¬ä¸€ååº”å±…ç„¶æ˜¯æƒ³åˆ°äº†æˆ‘çš„å®¢æˆ·ä»¬ã€‚

åšé—²é±¼å’Œæ·˜å®ä¹…äº†ï¼Œä½ ä¼šå‘çŽ°äººä¹Ÿæ˜¯æœ‰â€œå¤šé‡æž„è±¡â€çš„ã€‚åŒä¸€ä¸ªå®¢æˆ·ï¼Œä¹°ä¹‹å‰å«ä½ â€œäº²â€ï¼Œè¯­æ°”æ¸©æŸ”å¾—åƒåªçŒ«ï¼›ä¸€æ—¦è´¦å·å‡ºäº†ç‚¹å°é—®é¢˜ï¼ˆæ¯”å¦‚æ¢¯å­ä¸ç¨³è¿žä¸ä¸Šï¼‰ï¼Œç«‹é©¬å˜èº«â€œæš´èºè€å“¥â€ï¼Œæ¨ä¸å¾—é¡ºç€ç½‘çº¿è¿‡æ¥æŽæ­»ä½ ï¼›ç­‰ä½ å¸®ä»–è§£å†³äº†ï¼Œä»–åˆå˜æˆâ€œå¤§ç¥žç‰›é€¼â€ã€‚

è›‹ç™½è´¨ä¹Ÿæ˜¯ä¸€æ ·ï¼Œå®ƒåœ¨ç»†èƒžé‡Œä¸æ˜¯åƒµæ­»çš„ï¼Œå®ƒæ˜¯ä¼šåŠ¨ã€ä¼šå˜å½¢çš„ã€‚è¿™ç¯‡è®ºæ–‡è¯´ï¼ŒAFsample3 èƒ½é¢„æµ‹è¿™äº›å˜åŒ–ï¼Œå‡†ç¡®çŽ‡æš´æ¶¨ 54%ã€‚

è¿™ä¸€æ¡æ–°é—»å…¶å®žè®©æˆ‘æœ‰ç‚¹å…´å¥‹ã€‚ä¸ºä»€ä¹ˆï¼Ÿå› ä¸ºæˆ‘æ˜¯ä¸ªç”Ÿç‰©å°ç™½ï¼Œä½†æˆ‘çŸ¥é“ä¸€ç‚¹ï¼š**ç”Ÿå‘½åœ¨äºŽè¿åŠ¨**ã€‚å¦‚æžœ AI åªèƒ½é¢„æµ‹é™æ€çš„ç»“æž„ï¼Œé‚£å®ƒæ°¸è¿œé€ ä¸å‡ºçœŸæ­£çš„ç”Ÿå‘½ï¼Œä¹Ÿå°±æ²¡æ³•çœŸæ­£å¸®æˆ‘å»¶å¯¿ã€‚åªæœ‰æžæ‡‚äº†è¿™äº›å¾®è§‚åˆ†å­çš„â€œåŠ¨æ€èˆžæ­¥â€ï¼Œæˆ‘ä»¬æ‰ç®—çœŸçš„æ‘¸åˆ°äº†ç”Ÿå‘½çš„é—¨æ§›ã€‚

è™½ç„¶çŽ°åœ¨çš„æˆ‘ï¼Œè¿žé‚£ä¸ªè®ºæ–‡é‡Œçš„â€œå¤šé‡é‡‡æ ·ç®—æ³•â€åŽŸç†éƒ½çœ‹ä¸æ‡‚ï¼Œä½†ç›´è§‰å‘Šè¯‰æˆ‘ï¼Œè¿™æ¯”å•çº¯å¤šå‘çŽ°å‡ ä¸ªè¯ç‰©é¶ç‚¹è¦é‡è¦å¾—å¤šã€‚è¿™æ˜¯ä»Žâ€œæ‹ç…§â€åˆ°â€œæ‹è§†é¢‘â€çš„è·¨è¶Šã€‚

## AI å†™å‡ºé™¢å°ç»“ï¼Œæˆ‘æ˜¯ä¸æ•¢ä¿¡

å¦ä¸€æ¡æ–°é—»è®©æˆ‘æœ‰ç‚¹æƒ³åæ§½ã€‚

ã€ŠNature Scientific Reportsã€‹å‘äº†ç¯‡è®ºæ–‡ï¼Œè¯´ç”¨å¾®è°ƒçš„å¤§æ¨¡åž‹æ¥å†™å‡ºé™¢å°ç»“ï¼Œè¿˜èƒ½â€œè‡ªæˆ‘è¯„ä¼°â€å‡†ç¡®æ€§ã€‚

ä½œä¸ºä¸€ä¸ªé å– AI è´¦å·ä¸ºç”Ÿçš„äººï¼Œæˆ‘å¯¹å¤§æ¨¡åž‹çš„â€œå¹»è§‰â€ç®€ç›´å¤ªç†Ÿæ‚‰äº†ã€‚

åŽ»å¹´æˆ‘åœ¨é—²é±¼ä¸Šè¢«æ‰£åˆ†ï¼Œå°±æ˜¯å› ä¸ºæˆ‘ç”¨ GPT-4 å†™äº†ä¸€æ®µçœ‹èµ·æ¥æžå…¶ä¸“ä¸šçš„â€œè´¦å·ä½¿ç”¨å…è´£å£°æ˜Žâ€ï¼Œç»“æžœé‡Œé¢èƒ¡ç¼–ä¹±é€ äº†ä¸€æ¡ä¸å­˜åœ¨çš„é—²é±¼ç¤¾åŒºè§„åˆ™ï¼Œè¢«ç³»ç»Ÿåˆ¤å®šè¿è§„ã€‚å½“æ—¶æˆ‘è¿˜è§‰å¾—è‡ªå·±æŒºå†¤ï¼ŒçŽ°åœ¨æƒ³æƒ³ï¼ŒAI è¿™å®¶ä¼™ï¼Œå“ªæ€•åˆ°äº† 2026 å¹´ï¼Œä¸€æœ¬æ­£ç»èƒ¡è¯´å…«é“çš„æœ¬äº‹è¿˜æ˜¯åœ¨çš„ã€‚

æ–°é—»é‡Œè¯´è¿™ä¸ªæ¨¡åž‹èƒ½â€œè‡ªæˆ‘è¯„ä¼°â€ï¼Œæ£€æŸ¥è‡ªå·±çš„é”™è¯¯ã€‚è¿™é€»è¾‘å¬èµ·æ¥å°±åƒæ˜¯ï¼šä¸€ä¸ªé†‰æ±‰è¯´ä»–æ²¡é†‰ï¼Œå¹¶ä¸”å³ä½¿ä»–é†‰äº†ï¼Œä»–ä¹Ÿèƒ½é€šè¿‡è‡ªå·±é‚£é†‰é†ºé†ºçš„å¤§è„‘åˆ¤æ–­å‡ºè‡ªå·±é†‰äº†ã€‚

å¦‚æžœæˆ‘æ˜¯ç—…äººï¼Œçœ‹åˆ°åŒ»ç”Ÿæ‹¿ç€ AI ç”Ÿæˆçš„å•å­ç»™æˆ‘ï¼Œæˆ‘å¿ƒé‡Œç»å¯¹å‘æ¯›ã€‚

ä½†è½¬å¿µä¸€æƒ³ï¼ŒçŽ°å®žå¯èƒ½æ˜¯æ®‹é…·çš„ã€‚åŒ»ç”Ÿå¤ªå¿™äº†ï¼Œå†™æ–‡ä¹¦è¿™ç§æž¯ç‡¥çš„æ´»å„¿ï¼Œä»–ä»¬å·´ä¸å¾—ç”©ç»™ AIã€‚

è¿™è®©æˆ‘æƒ³åˆ°æˆ‘ä¹‹å‰å†™çš„é‚£ä¸‰ä¸ª AI è¯¾ç¨‹ã€‚å‡ åä¸‡å­—å•Šï¼Œå“ªæ€•æ²¡äººä¹°ï¼Œæˆ‘ä¹Ÿå†™å¾—çƒ­è¡€æ²¸è…¾ã€‚åŽæ¥ä¸ºäº†å‡‘å­—æ•°ï¼Œæˆ‘ä¹Ÿç”¨äº† AI æ‰©å†™ã€‚ç»“æžœå‘¢ï¼Ÿå­—æ•°æ˜¯ä¸ŠåŽ»äº†ï¼Œä½†é‚£éƒ¨åˆ†å†…å®¹è¯»èµ·æ¥å°±åƒç™½å¼€æ°´ï¼Œæ²¡å‘³å„¿ã€‚

åŒ»ç–—æ–‡ä¹¦è¦æ˜¯ä¹Ÿå˜æˆè¿™ç§â€œç™½å¼€æ°´â€ï¼Œä»¥åŽçœ‹ç—…ä¼šä¸ä¼šæ›´å†·å†°å†°äº†ï¼Ÿä¸è¿‡å¯¹äºŽåŒ»é™¢æ¥è¯´ï¼Œæ•ˆçŽ‡å°±æ˜¯é‡‘é’±ã€‚è¿™æŠ€æœ¯è½åœ°è‚¯å®šå¿«ï¼Œæ¯•ç«Ÿèƒ½çœäººå·¥ã€‚

## æœºå™¨äººç…§é•œå­ï¼Œæ¯”æˆ‘åšç›´æ’­è¿˜è‡ªç„¶

è¿˜æœ‰ä¸ªè¶£é—»ï¼Œè¯´å“¥ä¼¦æ¯”äºšå¤§å­¦æžäº†ä¸ªæœºå™¨äººï¼Œé€šè¿‡ç…§é•œå­å­¦ä¼šäº†è¯´è¯æ—¶æ€Žä¹ˆåŠ¨å˜´çš®å­ã€‚

çœ‹åˆ°è¿™å„¿æˆ‘ç¬‘äº†ã€‚æˆ‘æƒ³èµ·ä¸¤å¹´å‰ï¼Œæˆ‘åˆšå¼€å§‹åœ¨è§†é¢‘å·å°è¯•éœ²è„¸ç›´æ’­å–è¯¾ã€‚é‚£æ—¶å€™æˆ‘ç”šè‡³ä¸çŸ¥é“æ‰‹è¯¥å¾€å“ªæ”¾ï¼Œçœ¼ç›è¯¥çœ‹é•œå¤´è¿˜æ˜¯çœ‹å±å¹•ï¼Œå˜´å·´åŠ¨å¾—æžå…¶åƒµç¡¬ï¼Œçœ‹ç€å›žæ”¾æˆ‘éƒ½æƒ³æŠ½è‡ªå·±ã€‚

ç»“æžœçŽ°åœ¨æœºå™¨äººéƒ½èƒ½è‡ªå·±ç…§é•œå­å­¦ä¼šç®¡ç†è¡¨æƒ…äº†ï¼Ÿ

è¿™è®©æˆ‘æƒ³èµ·â€œææ€–è°·â€æ•ˆåº”ã€‚å¦‚æžœå“ªå¤©ï¼Œæˆ‘å–çš„ AI åŠ©æ‰‹ä¸ä»…ä»…æ˜¯ä¸€ä¸ªå¯¹è¯æ¡†ï¼Œè€Œæ˜¯ä¸€ä¸ªæœ‰ç€å®Œç¾Žè¡¨æƒ…ã€èƒ½çœ‹ç€æˆ‘çš„çœ¼ç›è¯´è¯çš„è™šæ‹Ÿäººï¼Œé‚£æˆ‘çš„ç”Ÿæ„ä¼šå˜å¥½è¿˜æ˜¯å˜åï¼Ÿ

ä¹Ÿè®¸åˆ°é‚£æ—¶ï¼Œæˆ‘å°±ä¸æ˜¯å–è´¦å·äº†ï¼Œæˆ‘æ˜¯å–â€œè™šæ‹Ÿä¼´ä¾£çš„çµé­‚ç¢Žç‰‡â€ã€‚è¿™å¬èµ·æ¥æ¯”å– Cursor æ¿€æ´»ç è¦èµ›åšæœ‹å…‹å¤šäº†ã€‚

## è¿˜æ˜¯ç»§ç»­å–é“²å­å§

çœ‹å®Œæ—¥æŠ¥ï¼Œåˆä¸Šç”µè„‘ï¼Œæˆ‘å–å®Œæœ€åŽä¸€å£å’–å•¡ã€‚

ä»Šå¤©çš„è¿™äº›çªç ´â€”â€”è›‹ç™½è´¨çš„å¤šæž„è±¡ã€åŒ»ç–—æ–‡ä¹¦çš„è‡ªåŠ¨åŒ–ã€æœºå™¨äººçš„è¡¨æƒ…ç®¡ç†â€”â€”æ¯ä¸€é¡¹éƒ½åœ¨æŠŠè¿™ä¸ªä¸–ç•Œå¾€æœªæ¥æŽ¨ä¸€æ­¥ã€‚

è™½ç„¶ç¦»æˆ‘æ¢¦æƒ³çš„â€œé•¿ç”Ÿä¸è€â€è¿˜æœ‰å¾ˆè¿œï¼Œè™½ç„¶ DeepSeek è¿˜æ˜¯å¶å°”ä¼šå´©ï¼Œè™½ç„¶æˆ‘çš„é—²é±¼åº—å¶å°”è¿˜æ˜¯ä¼šæ”¶åˆ°å·®è¯„ï¼Œä½†åªè¦æŠ€æœ¯è¿˜åœ¨åŠ¨ï¼Œæˆ‘å°±è§‰å¾—æœ‰å¸Œæœ›ã€‚

å¯¹äºŽæˆ‘è¿™ä¸ªâ€œå–é“²å­â€çš„äººæ¥è¯´ï¼ŒæŠ€æœ¯è¶Šå¤æ‚ï¼Œæ™®é€šäººè¶Šçœ‹ä¸æ‡‚ï¼Œæˆ‘çš„æœºä¼šå°±è¶Šå¤šã€‚

åˆšæ‰æ‰‹æœºéœ‡äº†ä¸€ä¸‹ï¼Œåˆæœ‰ä¸ªå®¢æˆ·é—®ï¼šâ€œè€æ¿ï¼Œä½ è¿™æœ‰é‚£ç§èƒ½åˆ†æžåŒ»å­¦è®ºæ–‡çš„ AI è´¦å·å—ï¼Ÿæˆ‘å†™æ¯•ä¸šè®ºæ–‡æ€¥ç”¨ã€‚â€

çœ‹ï¼Œéœ€æ±‚è¿™ä¸å°±æ¥äº†å—ï¼Ÿ

æˆ‘å›žäº†ä¸€å¥ï¼šâ€œæœ‰ï¼Œæ‹ä¸‰åˆä¸€é‚£ä¸ªé“¾æŽ¥ï¼Œç®¡å¤Ÿã€‚â€

æ—¥å­è¿˜å¾—è¿‡ï¼Œé•¿ç”Ÿä¸è€å…ˆæ”¾ä¸€æ”¾ï¼Œå…ˆæŠŠä»Šå¤©çš„é¥­é’±æŒ£äº†ã€‚

---

> ðŸ“° å®Œæ•´ç‰ˆæ—¥æŠ¥è¯·ï¿½ï¿½?[BioAI ç”Ÿå‘½ç§‘å­¦æ—¥æŠ¥](https://news.aibioo.cn/2026-01/2026-01-18/)
